Gilead Sciences (GILD) Return on Capital Employed (2009 - 2026)

Gilead Sciences has reported Return on Capital Employed for 18 years, with the latest figure at 21.53% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 341.0% year-over-year to 21.53%; the trailing twelve-month figure through Mar 2026 stood at 21.53% (up 341.0% YoY), and the FY2025 full-year result was 21.23%, up 1781.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 21.53%, up from 21.34% in the prior quarter.
• The five-year high for Return on Capital Employed was 23.4% in Q3 2025, with the low at 1.94% in Q3 2024.
• Historically, Return on Capital Employed has averaged 13.79% across 5 years, with a median of 14.92% in 2023.
• Annual changes were most pronounced in 2024 — Return on Capital Employed sank 1444 bps — and 2025, when it soared 2146 bps.
• Gilead Sciences' Return on Capital Employed stood at 14.2% in 2022, then increased by 5 bps to 14.92% in 2023, then plunged by 75 bps to 3.71% in 2024, then soared by 475 bps to 21.34% in 2025, then advanced by 1 bps to 21.53% in 2026.
• The last three Return on Capital Employed figures came in at 21.53% (Q1 2026), 21.34% (Q4 2025), and 23.4% (Q3 2025), per Business Quant data.